Prescription drug pricing: An overview of the legal, regulatory, and market environment

Joseph Antos and James Capretta
Additional contact information
James Capretta: American Enterprise Institute

AEI Economic Perspectives, 2018

Abstract: Policymakers should study the existing arrangements carefully and consider what can be done to promote more supply competition (thus minimizing monopolistic pricing) in all drug categories.

Keywords: pharmaceuticals; drug policy; drugs; AEI Economic Perspectives; prescription (search for similar items in EconPapers)
JEL-codes: A (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.aei.org/wp-content/uploads/2018/07/Pre ... g-Pricing.pdf?x91208 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aei:journl:y:2018:id:989513

Access Statistics for this article

More articles in AEI Economic Perspectives from American Enterprise Institute Contact information at EDIRC.
Bibliographic data for series maintained by Dave Adams, CIO ().